USFDA brings mixed results for Indian pharma
CNX IT: Downside levels to be watched is around 9850-9800 in the next 1-2 weeks
NSE Bank: Continue to maintain or create fresh long positions in Banking sector
Central Banks, Avengers Of Our Esoteric Financial World
Bad medicine?: Weak domestic regulation is affecting the Indian pharma sector
Metals/Steel: New challenges ahead; Motilal Oswal recommend JSPL as their top pick
Auto Sales: 2 wheeler, passenger vehicle & commercial vehicle up 1%, 10% & 7% resp. in Mar'17
Telecom Sector: Vodafone-Idea merger could happen faster than expected
Banking Stocks Will Be In Focus
NSE Banks: Expect upside bounce back in the sector
View all >>